Clinical Trials Browser

Phase 2 × Not yet recruiting × Platinum × Clear all

NCT07376499 2026-01-29

Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT07276360 2025-12-11

HypoRTCx-UG

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT07138001 2025-08-22

Phase 2 Clinical Trial of KH617

Phase 2 Not yet recruiting

Glioblastoma

NCT07097948 2025-08-01

Adjuvant

Phase 2 Not yet recruiting

Recurrence, Small Cell Lung Carcinoma

NCT06648200 2024-10-18

Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer

Phase 2 Not yet recruiting

Recurrence, Small Cell Lung Carcinoma

NCT06128460 2023-11-30

Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer.

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT06142617 2023-11-21

A Prospective Study of Pembrolizumab Combining Chemotherapy in Advanced NSCLC Patients With EGFR Exon 21 Point Mutation.

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung